Troy Lister's most recent trade in Verve Therapeutics Inc was a trade of 225,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Verve Therapeutics Inc | Troy Lister | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
Verve Therapeutics Inc | Troy Lister | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
Verve Therapeutics Inc | Troy Lister | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) |